Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Procter & Gamble (NY: PG )

161.02 +1.49 (+0.93%)
Official Closing Price Updated: 7:00 PM EDT, Apr 25, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Procter & Gamble

< Previous 1 2
...
26 27 28 29 30 31 32 33 34
...
72 73 Next >
Benzinga's Top Ratings Upgrades, Downgrades For September 22, 2023
Via Benzinga
3 No-Brainer Stocks to Buy in a Correction
Large, well-run companies often get cheaper when Wall Street hits the skids, despite their proven staying power. 
Via The Motley Fool
P&G to Webcast Discussion of First Quarter 2023/24 Earnings Results on October 18
From Procter & Gamble
Via Business Wire
Looking At Procter & Gamble's Recent Unusual Options Activity
Via Benzinga
Procter & Gamble Unusual Options Activity
Via Benzinga
Analyst Ratings for Procter & Gamble
Via Benzinga
Oil Price Predictions 2023: When Will Crude Hit $100 Per Barrel?
Supply cuts and geopolitical events have prompted high oil price predictions. So, is your portfolio shielded from an "oil shock"? 
Via InvestorPlace
3 Safe Dividend Stocks to Buy Like There's No Tomorrow
The refining industry is a cause of inflation, not a victim. 
Via The Motley Fool
Topics Economy
Exposures Interest Rates
Got $2,500? 2 Top Stocks That You Can Buy and Hold for a Lifetime
Put these stocks in your portfolio and watch them grow. 
Via The Motley Fool
Dividend Income Update August 2023
Let’s take a look at my August 2023 dividend income. 
Via Talk Markets
Dividend Yield: Why it Matters
Via MarketBeat
Better Stock Buy: Coca-Cola vs. Procter & Gamble
These iconic consumer staples stocks are usually afforded premium prices, but one is a bit more attractively priced. 
Via The Motley Fool
You Can't Control Activist Investors, but You Can Control What You Do About Them
Unilever and Procter & Gamble have both had to deal with activist investor Nelson Peltz agitating for change. 
Via The Motley Fool
Lawsuit Against Dummy Pills For Allergy, Cold: Johnson & Johnson And Procter & Gamble Face Allegations
In a recent lawsuit, Johnson & Johnson (NYSE: JNJ) and Procter & Gamble Co (NYSE: PG) are facing allegations of misleading consumers regarding decongestant cold medicines conta 
Via Benzinga
Topics Lawsuit
Exposures Financial Legal
The 7 Most Undervalued Blue-Chip Stocks to Buy in September 2023
If you're looking for less risky stocks that can still generate solid returns, take a look at these top blue-chip stocks. 
Via InvestorPlace
Zevo On-Body Mosquito + Tick Repellents Earn Coveted Good Housekeeping Seal of Approval
From Procter & Gamble
Via Business Wire
Best Dividend Stocks: Coca-Cola vs. Procter & Gamble
Dividend stocks have historically performed relatively better than growth stocks during an economic downturn. 
Via The Motley Fool
Buy the Dip: 3 Consumer Stocks to Snag Now for Supercharged Gains
Amidst economic turbulence, explore these consumer stocks to buy on the dip, offering tremendous long-term upside ahead. 
Via InvestorPlace
FDA Panel Says Popular OTC Cold, Allergy Medicine Might Be Useless - Stocks To Watch
According to FDA panel experts who reviewed the latest research on the long-questioned phenylephrine, a drug ingredient used in several leading decongestants used by millions of Americans looking for... 
Via Benzinga
Exposures Product Safety
Sunscreen Cosmetics Market to Eyewitness Massive Growth : L'oreal, Beiersdorf, Clarins
Stay up-to-date with Sunscreen Cosmetics Market research offered by AMA Research. Check how key trends and emerging drivers are shaping this industry growth. 
Via SBWire
3 Penny Stocks to Invest In for Big-Time, Long-Term Gains
These penny stocks provide investors with the potential for massive capital appreciation over a multi-year investment period. 
Via InvestorPlace
New to Investing? Here's How You Can Get Started With $500.
You don't have to invest a lot to start building a winning portfolio. 
Via The Motley Fool
2 Vanguard ETFs That Could Turn $200 per Month Into $395,000 or More
With enough time, you could potentially earn well over $1 million with these ETFs. 
Via The Motley Fool
Topics ETFs
Up 104% YTD, Has Tesla Stock Run Too Far Too Fast?
A look at Tesla's valuation and if it can be justified. 
Via The Motley Fool
Benzinga's Top Ratings Upgrades, Downgrades For September 8, 2023
Via Benzinga
7 Best Blue Chip Stocks to Buy Now
Blue-chip stocks are the stocks of well-known, high-quality industry leaders. Learn more about our top picks for the best blue chip stocks to buy now. 
Via MarketBeat
3 Dividend Kings Poised to Outperform the Market
Wall Street expects these three Dividend Kings who have raised their dividend payments for 50 or more consecutive years to keep delivering dividend gold. 
Via MarketBeat
3 Reasons Why You Should Invest in Dividend Kings
There are dividend stocks and then there are Dividend Kings. It's hard to argue with the kind of success they've achieved. 
Via The Motley Fool
Does It Make Sense to Invest in a Company With Its Name on a Stadium?
Look beyond the big print. 
Via The Motley Fool
Is Procter & Gamble a Buy Now?
The iconic consumer goods company's yield is middle-of-the-road, historically speaking. While not a screaming buy, some might like it here. 
Via The Motley Fool
< Previous 1 2
...
26 27 28 29 30 31 32 33 34
...
72 73 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.